Mr. Satterfield recalls the informed consent form which he signed. He found it a fairly smooth process, although there was a requirement to send some tissue samples to the clinical trial organizers. There was a delay of about 3 weeks before the trial could begin. Based on his tissue samples and his patient history, he was eligible to join the clinical trial. He followed the trial steps with regular treatments and monitoring. By May 2017, the doctor told him there were no more signs of the cancer in his body.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.